Condition
Diabetes Mellitus, Type 2
Locations
Singapore
Start date
13/03/2026
Identifiers
Trial ID DAS-8606,
NCT number NCT07532863,
Eudract number Not Available
NCT number NCT07532863,
Eudract number Not Available
Summary
The purpose of the study is to investigate the cardiovascular disease (CVD) risk profile among participants newly diagnosed with type 2 diabetes mellitus (T2DM) in Southeast Asia (CRISTAL SEA). It's a retrospective chart-review across five Southeast Asian countries to characterize newly diagnosed T2DM participants and how their CVD risk is distributed, using data from the year before diagnosis and roughly the first year after diagnosis.
Trial Overview:
Treatment
OTHER: No treatment given
Study type
OBSERVATIONAL
Trial duration
Mar 13 2026 - Mar 27 2027
Participants
400
Phase
Not Available
Are you eligible?
Gender
Male and female
Age
40 to 70 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.